Search results
Results from the WOW.Com Content Network
Changes in the eye can help predict other health concerns in the body, such as diabetes and high blood pressure. A new study has identified a set of 29 vascular health indicators on the retina ...
Aside from cancer, epiphenotyping has been done to predict an individual's risk for other diseases including Alzheimer's disease and cardiovascular disease. [45] [46] Another application of epiphenotyping includes predicting cell-type compositions within bulk tissue samples.
The goal of predictive medicine is to predict the probability of future disease so that health care professionals and the patient themselves can be proactive in instituting lifestyle modifications and increased physician surveillance, such as bi-annual full body skin exams by a dermatologist or internist if their patient is found to have an increased risk of melanoma, an EKG and cardiology ...
AI has been explored for use in cancer diagnosis, risk stratification, molecular characterization of tumors, and cancer drug discovery. A particular challenge in oncologic care that AI is being developed to address is the ability to accurately predict which treatment protocols will be best suited for each patient based on their individual ...
It can occur at any age, but hormonal changes following menopause increase the likelihood of coronary artery disease — the build-up of plaques in the arteries that can lead to heart attack.
A new approach to a routine blood test could predict a person’s 30-year risk of heart disease, research published Saturday in the New England Journal of Medicine found.. Doctors have long ...
The two graphics illustrate sampling distributions of polygenic scores and the predictive ability of stratified sampling on polygenic risk score with increasing age. + The left panel shows how risk—(the standardized PRS on the x-axis)—can separate 'cases' (i.e., individuals with a certain disease, (red)) from the 'controls' (individuals without the disease, (blue)).
In addition to giving patients a better idea of their cancer risk, doctors may be able to use the findings to determine whether some patients with BRCA2-driven cancers might benefit from targeted ...